PMV Pharmaceuticals, Inc.

Rachunek Zysków i Strat kwartalnie


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23
Rok finansowy 2019 2019 2019 2019 2020 2020 2020 2020 2021 2021 2021 2021 2022 2022 2022 2022 2023 2023 2023 2023 2024 2024 2024 2024
Data 2019-03-31 2019-06-30 2019-09-30 2019-12-31 2020-03-31 2020-06-30 2020-09-30 2020-12-31 2021-03-31 2021-06-30 2021-09-30 2021-12-31 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30 2024-09-30 2024-12-31
Kwartał Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
Przychód (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0
Przychód Δ kw/kw 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% inf% 0.0% 0.0% 0.0% <span style="color:red">-100.00%</span>
Marża brutto 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% <span style="color:red">-inf%</span> <span style="color:red">-inf%</span> <span style="color:red">-inf%</span> <span style="color:red">-inf%</span> <span style="color:red">-inf%</span> <span style="color:red">-inf%</span> <span style="color:red">-inf%</span> <span style="color:red">-inf%</span> <span style="color:red">-inf%</span> <span style="color:red">-inf%</span> <span style="color:red">-inf%</span> 77.8% <span style="color:red">-inf%</span> <span style="color:red">-inf%</span> 0.0% 0.0%
Koszty i Wydatki (mln) 6 6 6 7 8 8 9 11 12 13 15 18 19 18 19 21 21 20 20 19 18 20 22 25
EBIT (mln) -6 -6 -6 -7 -8 -8 -9 -11 -12 -13 -15 -18 -19 -18 -19 -21 -21 -20 -20 -19 -18 -20 -22 -25
EBIT Δ kw/kw 16.1% 20.6% 26.0% 30.0% 34.4% 38.0% 42.4% 43.2% 37.3% 27.0% 22.1% 12.7% 13.3% 11.1% 1.3% 12.0% 17.9% 0.2% 10.3% 0.0% 0.0% 0.0% 0.0% 242.2%
EBIT (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% <span style="color:red">-1168.23%</span> 0.0% 0.0% 0.0% nan
Przychody fiansowe (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 2 2 3 3 3 3 3 3 2
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 2 0 0 0 0
Amortyzacja (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
EBITDA (mln) -6 -6 -6 -7 -8 -8 -9 -10 -12 -13 -15 -18 -19 -18 -19 -21 -21 -20 -19 -19 -17 -20 -22 -25
EBITDA(%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% <span style="color:red">-1146.04%</span> 0.0% 0.0% 0.0% nan
NOPLAT (mln) -6 -6 -6 -7 -7 -8 -9 -10 -12 -13 -15 -18 -18 -17 -18 -19 -19 -17 -17 -16 -15 -17 -19 -23
Podatek (mln) 0 0 0 0 0 -0 0 0 0 -0 0 0 0 -0 -0 -0 -2 0 -0 -0 0 -16 0 0
Zysk Netto (mln) -6 -6 -6 -7 -7 -8 -9 -10 -12 -13 -15 -18 -18 -17 -18 -19 -17 -17 -17 -16 -15 -1 -19 -23
Zysk netto Δ kw/kw 0.0% 0.0% 0.0% 0.0% 19.8% 31.5% 41.9% 48.3% 59.9% 61.6% 71.3% 75.6% 58.9% 34.5% 21.4% 5.3% <span style="color:red">-8.99%</span> 0.7% <span style="color:red">-8.72%</span> <span style="color:red">-18.48%</span> <span style="color:red">-8.98%</span> <span style="color:red">-93.04%</span> 15.5% 46.0%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% <span style="color:red">-973.79%</span> 0.0% 0.0% 0.0% nan
EPS -2.0 -2.0 -0.2 -0.23 -0.23 -0.19 -1.46 -1.74 -0.26 -0.29 -0.33 -0.41 -0.41 -0.38 -0.4 -0.42 -0.37 -0.38 -0.34 -0.31 -0.3 -0.0236 -0.37 0.37
EPS (rozwodnione) -2.0 -2.0 -0.2 -0.23 -0.23 -0.19 -1.46 -1.74 -0.26 -0.29 -0.33 -0.41 -0.41 -0.38 -0.4 -0.42 -0.37 -0.38 -0.34 -0.31 -0.3 -0.0236 -0.37 0.37
Ilośc akcji (mln) 3 3 31 31 31 43 6 6 45 45 45 45 45 46 46 46 46 46 49 51 51 51 52 52
Ważona ilośc akcji (mln) 3 3 31 31 31 43 6 6 45 45 45 45 45 46 46 46 46 46 49 51 51 51 52 52
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD